Dogwood Therapeutics, Inc (DWTX) vs PDS Biotechnology Corporation (PDSB)

Dogwood Therapeutics, Inc and PDS Biotechnology Corporation are both Biotechnology companies. Dogwood Therapeutics, Inc and PDS Biotechnology Corporation are of similar size ($48.6M and $44.2M). Across the 9 metrics below, Dogwood Therapeutics, Inc leads on 6 and PDS Biotechnology Corporation on 3.

Valuation

Metric DWTX PDSB Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.68 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (658.09%) (80.00%) (28.84%)
Free cash flow yield (32.55%) (37.14%) (23.03%)

Profitability

Metric DWTX PDSB Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (143.45%) (543.97%) (57.72%)
Return on assets (40.68%) (136.65%) (49.22%)
Return on invested capital (41.22%) 0.00% 0.00%

Growth

Metric DWTX PDSB Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 43.05% 28.16% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DWTX PDSB Biotechnology median
Debt to equity 0.00 (1.21) 0.00
Current ratio 3.89 0.57 4.73
Net debt to EBITDA 0.23 0.50 0.96

Dividend

Metric DWTX PDSB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric DWTX PDSB Biotechnology median
Market cap 48.61m 44.21m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack